Berry Genomics Co.,Ltd (SHE:000710)
China flag China · Delayed Price · Currency is CNY
9.57
-0.42 (-4.20%)
Aug 11, 2026, 3:04 PM CST

Berry Genomics Co.,Ltd Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
301.59379.51383.07338.15333.56417.89
Trading Asset Securities
2.822.8217.0313.864.513.82
Cash & Short-Term Investments
304.41382.33400.1352.01338.07421.7
Cash Growth
-15.93%-4.44%13.66%4.12%-19.83%-33.39%
Accounts Receivable
559.74549.34695.17815.211,0631,109
Other Receivables
50.1456.0576.454.9714.5134.07
Receivables
609.88605.38771.62820.181,0771,143
Inventory
178.03176.76194.91229.3230.95233.88
Prepaid Expenses
-0.080.010.140.211.88
Other Current Assets
84.6679.5272.4571.3780.15105.88
Total Current Assets
1,1771,2441,4391,4731,7271,907
Property, Plant & Equipment
513.08519.91459.07923.421,1011,131
Long-Term Investments
194.24187.75177.1948.45138.26279.07
Goodwill
13.4313.4313.4313.4313.4313.43
Other Intangible Assets
64.366.431.6849.6751.652.21
Long-Term Accounts Receivable
--0.31---
Long-Term Deferred Tax Assets
150.44150.42144.07151.27104.863.93
Long-Term Deferred Charges
103.28102.2489.7748.4441.0446.71
Other Long-Term Assets
--30.1133.4926.6627.05
Total Assets
2,2162,2842,3852,7413,2033,520

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
211.38272.91287.51292.48278.9339.93
Accrued Expenses
44.4452.4155.8164.9563.1466.16
Short-Term Debt
155.08154.32113.42202.64203.69190.54
Current Portion of Long-Term Debt
---42.3--
Current Portion of Leases
6.3111.553.6312.95139.44
Current Income Taxes Payable
1.062.913.911.910.3813.44
Current Unearned Revenue
120.8119.66103.49110.75103.5690.55
Other Current Liabilities
20.4622.2422.8125.1142.0558.52
Total Current Liabilities
559.55635.99590.56763.09704.72768.58
Long-Term Debt
---42.18126.6185.7
Long-Term Leases
108.43107.2943.243.54.8813.62
Long-Term Unearned Revenue
11.0310.9410.8711.0212.073.66
Long-Term Deferred Tax Liabilities
25.9725.9224.926.7725.8924.46
Total Liabilities
704.97780.14669.56846.56874.17996.02

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
353.52353.52353.52353.52354.61354.61
Additional Paid-In Capital
1,1631,1631,1591,1561,2111,160
Retained Earnings
-76.06-56.32145.39337.82765.021,020
Treasury Stock
-----44.52-44.52
Comprehensive Income & Other
12.9216.4121.116.515.390.63
Total Common Equity
1,4531,4761,6791,8642,3012,490
Minority Interest
57.7627.8535.6930.5727.9433.51
Shareholders' Equity
1,5111,5041,7151,8952,3292,524
Total Liabilities & Equity
2,2162,2842,3852,7413,2033,520

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
269.83273.15160.28303.58348.17399.3
Net Cash (Debt)
34.59109.18239.8248.43-10.1122.4
Net Cash Growth
-64.83%-54.47%395.21%---91.81%
Net Cash Per Share
0.100.310.680.14-0.030.06
Filing Date Shares Outstanding
353.52353.52353.52353.52353.52353.52
Total Common Shares Outstanding
353.52353.52353.52353.52353.52353.52
Working Capital
617.44608.09848.53709.91,0221,138
Book Value Per Share
4.114.184.755.276.517.04
Tangible Book Value
1,3751,3961,6341,8012,2362,425
Tangible Book Value Per Share
3.893.954.625.096.336.86
Buildings
-317.47317.47606.22684.23684.08
Machinery
-647.34623.32638.82591.45553.45
Construction In Progress
-9.51-230.8290.95267.6